Trade Mark Journal No.2026/040 2 October 2026
WO0000001929063 (1,3,5,31,42)
Office of origin: United States of America
Date of International Registration:24 December 2025
Date of designation in the UK:
24 December 2025
The mark consists of a circle overlapping with a square, overlapping with an upside-down triangle.
International priority date claimed: 27 June 2025
(United States of America)
(99257154)
- Class 1
- Plant growth promoters and plant growth regulators in the nature of plant hormones for promoting plant growth, and biological soil and plant soil amendments for use in agriculture and horticulture; seed microbial inoculants and soil inoculants for use in agriculture and horticulture; biochemicals, namely, biological signal molecules in the nature of agricultural and horticultural chemicals, except fungicides, herbicides, insecticides and parasiticides, namely, natural and synthetic plant hormones, biological fertilizers, granulated fertilizers, and chemical additives for use in the manufacture of pesticides, insecticides, herbicides, biological pesticides, biological insecticides, and granulated pesticides that improve plant health and enhance growth of agricultural and horticultural crops; chemicals used in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides, namely seed treatment preparations; fertilizers for agricultural, domestic, horticultural, ornamental and commercial use; chemical preparations for the treatment of seeds and plants for agricultural use.
- Class 3
- Cosmetic skin and hair care preparations for use in connection with the improvement in the appearance of human skin.
- Class 5
- Pharmaceutical preparations for suppressing tumors and treatment of cancer; pharmaceuticals for use in the treatment of immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders; veterinary preparations for treatment of cancer, immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders for use in connection with pet animals and farm animals.
- Class 31
- Agricultural, horticultural and forestry products, namely, seeds and bulbs for agricultural and horticultural purposes, seedlings, live plant grafts, and plugs being seedlings or live rooted plant cuttings and planting soil sold as a unit; raw and unprocessed agricultural and horticultural products, namely, plant biomass being organic matter derived from live plants; natural live plants, rootstocks and flowers; live bulbs, seedlings, plant bulb divisions in the nature of live plant cuttings being parts of live plants, micropropagated seeds for agricultural and horticultural purposes, tissue-cultured seedlings, and seeds for planting for agricultural and horticultural purposes; agricultural and aqua-cultural crops, namely, crop seeds for agricultural and horticultural purposes and live plant cuttings and divisions being parts of live plants; horticulture and forestry products, namely, unprocessed seeds for planting for aqua-cultural and forestry use.
- Class 42
- Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract scientific research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals, namely, pharmaceutical research and development; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; scientific and technological services, namely, scientific research and design for others in the field of pharmaceuticals and conducting and evaluating clinical trials for others; software as a service (SaaS) services featuring software enabling users to diagnose medical conditions, prescribe medical treatment and prescriptions, design clinical trials and forecast clinical trial results, search for clinical trial patients, analyze data, and develop pharmaceutical products and chemical compounds.
Enveda Therapeutics, Inc.
Representative: J A Kemp LLP, 80 Turnmill Street London EC1M 5QU UNITED KINGDOM